Learn the skills, strategies, tools, and actionable techniques to address disruptions in medication supplies, now and in the future.
About the Program
This online program is designed to prepare diverse stakeholders in healthcare to address disruptions in medication supplies caused by drug shortages. Participants will receive the training and resources required to develop practical strategies and a certificate of completion at the end of the program.
Start | June 19th, 2023
Duration | 8 to 10 hours
Location | Virtual
Fees | $650 by June 5th, $699 after June 5th
Registration Deadline | June 15th, 2023
Participants will receive the training and resources required to develop practical strategies and a certificate of completion at the end of the program. You will have access to this online program starting on June 19th, 2023. You will have until August 21st, 2023 to complete the program to receive the certificate. You will not have access to the program after August 21st, 2023. Please be mindful of all dates (open and close) when enrolling in the program.
Benefits
By participating in this program, you will:
- Gain the skills, strategies, tools, and actionable techniques to address disruptions in medication supplies, now and into the future.
- Enhance your confidence and be better equipped to address disruptions in medication supplies caused by drug shortages.
- Acquire the knowledge to create initiatives and safeguards that target the most pressing issues around drug shortages at your institution or practice.
- Expand your perspective through exposure to diverse perspectives and information.
-
Apply the gained knowledge in practice to help save time and decrease the impact that drug shortages have on patient care.
What you will learn
Module 1 | Comprehensive introduction to drug shortages
Module 2 | Macro- and micro-level details and realities of the drug shortage crisis
Module 3 | What experiencing drug shortages has done for healthcare delivery and public health
Module 4 | Lessons learned: what facing drug shortages have taught us over the years
Module 5 | Actionable strategies to utilize moving forward
Who should attend
Executives
- Healthcare executives (e.g., CEO, COO, senior executives)
- Department heads/directors, clinical executives
- Administrators or managers
Front-line Healthcare Staff
- Healthcare providers (e.g., pharmacists, physicians, nurses)
- Pharmacy and therapeutics committee members
- Supplier(s) & purchaser(s)
- Informatics team
-
Pharmacy technicians
Policymakers
- Individuals in public and private sectors developing policies pertaining to medications.
Other professionals interested in drug shortages are welcome to join the program.
This program is designed for diverse stakeholders in healthcare at all stages of their careers. Early, mid -, and senior professionals must be equipped to address the drug shortages. Several stakeholders and players have stepped up and are at the forefront of addressing access to medication concerns caused by drug shortages.
The lessons outlined in this program apply to professionals in all facilities, regardless of size, and across various healthcare settings (e.g., inpatient, outpatient, hospitals, clinical, medical groups, immediate and acute care settings, and community settings).
More program details can be found here.
Featured
Meet the faculty
Dr. Rola Kaakeh
CEO at Salus Vitae Group
Adjunct Faculty at Northwestern University Feinberg School of Medicine
Dr. Rola Kaakeh is a fellowship-trained, licensed pharmacist with over fourteen years of experience in various settings (pharmacy practice, managed care, health systems, administration, public health and higher education). She is also affiliate faculty at the Northwestern University Institute for Global Health and Institute for Public Health and Medicine. Her impact has stretched across the international community to encompass overarching holistic countrywide policies to local, on the ground initiatives. She advises organizations globally on health system development, and has engaged with various institutions within the public and private sectors, non-governmental agencies such as the United Nations, universities, startups, and professional associations.
Her work highlighting the burden of drug shortages in the US has been cited over 200 times and used as supporting data for national policies and regulations. She has been very involved in education and training regarding the management of drug shortages, understanding the various dynamics involved, and helping evaluate and design processes (from institution to policy level) to improve access to medications. She comes to you with over a decade of experience in this space.
Have Questions?
Do you have questions and need more information? Email us at [email protected]. We would be delighted to discuss the program with you and answer all your questions. Read more about the program here.